Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Saved in:
| Title: | Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein. |
|---|---|
| Authors: | Upasani V; Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom., Townsend K; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Wu MY; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom., Carr EJ; Francis Crick Institute, London, United Kingdom.; Department of Renal Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom., Hobbs A; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom., Dowgier G; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom., Ragno M; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom., Herman LS; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom., Sharma S; Department of Elderly Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom., Shah D; Department of Elderly Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom., Lee SFK; Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, United Kingdom., Chauhan N; Department of Haematology, Royal Free London NHS Foundation Trust, London, United Kingdom., Glanville JM; Department of Haematology, Royal Free London NHS Foundation Trust, London, United Kingdom., Neave L; Department of Haematology, Royal Free London NHS Foundation Trust, London, United Kingdom., Hanson S; Department of Haematology, Royal Free London NHS Foundation Trust, London, United Kingdom., Ravichandran S; Department of Haematology, Royal Free London NHS Foundation Trust, London, United Kingdom., Tynan A; Department of Pharmacy, Royal Free London NHS Foundation Trust, London, United Kingdom., O'Sullivan M; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Moreira F; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Workman S; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Symes A; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Burns SO; Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Tadros S; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Hart JCL; Department of Virology, Royal Free London NHS Foundation Trust, London, United Kingdom., Beale RCL; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom.; Department of Renal Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom., Gandhi S; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom.; UCL Hospitals Biomedical Research Centre, London, United Kingdom., Wall EC; COVID Surveillance Unit, Francis Crick Institute, London, United Kingdom.; UCL Hospitals Biomedical Research Centre, London, United Kingdom., McCoy L; Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom., Lowe DM; Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.; Department of Clinical Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Oct 05; Vol. 77 (7), pp. 950-960. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
